National Taiwan University Hospital: Liver Diseases trials

The registry lists 12 Liver Diseases studies with National Taiwan University Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 3 2Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical TrialsRecruitingNCT06873165Not applicable
• Liver Fibrosis Assessment in Diabetic PatientsNot yet recruitingNCT06694974Not applicable
• Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
• Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLDStatus unknownNCT05686174Phase 1
• A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05308160Phase 3
• The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney DiseaseStatus unknownNCT05215964
• Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric SurgeryStatus unknownNCT04501042
• Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver DiseaseActive, not recruitingNCT04463667Not applicable
• To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular CarcinomaStatus unknownNCT02074202Phase 3
• Antinociceptive Modalities on Ischemia Reperfusion InjuryCompletedNCT01932918
• Quantitative Diagnosis of Fatty Liver by Dual Energy CT TechniqueStatus unknownNCT00172705
• Intravenous-Morphine and Glucagon-Usage Enhanced MR CholangiographyStatus unknownNCT00155376Phase 4